Sandoz launches first generic version of ATACAND®
Princeton, New Jersey, May 22, 2013 – Sandoz today announced the US Food and Drug Administration (FDA) approval and US launch of candesartan cilexetil tablets, the first generic version of ATACAND®. Candesartan cilexetil tablets are indicated to treat some types of heart failure in adults with left ventricular systolic dysfunction, and hypertension in adults and children […]